Leptin, heritability and a defended set point. Appetite turned out to be a hormonal signal rather than a character trait.
Obesity has been formally classified as a disease by major medical bodies for over a decade — the American Medical Association adopted that position in 2013, and others have followed. The World Health Organization had already classified it as a chronic condition well before that.
This was not a sentimental decision. It followed evidence that body weight is regulated by identifiable biological systems, that those systems can be disordered, and that the disorder produces measurable harm.
Three findings in particular made the old framing untenable.
It is worth being precise, because the argument is often conducted against a position nobody holds.
It does claim that body weight is regulated biologically, that the regulation varies between people for reasons they did not choose, and that treating the resulting condition is legitimate medicine.
It does not claim that behaviour is irrelevant, that nothing can be done, or that every person above a BMI threshold is ill. Plenty of people at a higher weight are metabolically healthy, and plenty at a normal weight are not.
There is a reasonable criticism of the disease label, and it deserves stating rather than dismissing.
BMI is a poor instrument for an individual. Defining a disease by a height‑weight ratio labels some healthy people as ill, and misses unhealthy people who fall below the threshold. Several groups — including a 2025 Lancet commission — have proposed moving towards definitions based on measured organ dysfunction rather than BMI alone, distinguishing clinical obesity from a merely raised BMI.
That is a live and unresolved debate. It is also the reason a careful clinic measures a panel and a waist rather than putting someone on a scale and reading a number off a chart.
The practical consequences of the reclassification are real:
The risks associated with obesity — type 2 diabetes, fatty liver, sleep apnoea, several cancers, osteoarthritis, cardiovascular disease — are well documented. But the relationship is not a straight line from weight to harm, and where fat sits matters as much as how much there is.
Which is why the useful clinical question is not "what do you weigh" but "what are your glucose, your lipids, your liver enzymes, your blood pressure and your waist doing".
Nothing here says whether you have a condition that needs treating, or what that treatment should be. That rests on measurements, history and a conversation with a physician.
What it does say is that if you have been carrying this as a personal failing, the medical profession formally stopped framing it that way more than a decade ago. That is not encouragement; it is simply where the evidence went.
Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.
Measure my biomarkers